Open6.420 | Close6.290 |
Vol / Avg.2.028M / 2.833M | Mkt Cap1.327B |
Day Range6.240 - 6.540 | 52 Wk Range4.015 - 12.340 |
Hims & Hers Health Stock (NYSE: HIMS) stock price, news, charts, stock research, profile.
Open6.420 | Close6.290 |
Vol / Avg.2.028M / 2.833M | Mkt Cap1.327B |
Day Range6.240 - 6.540 | 52 Wk Range4.015 - 12.340 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.030 | (EXPECTED) 2023-11-06 | |||||
REV | 220.050M |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.060 | -0.030 | 0.0300 | ||||
REV | 204.620M | 207.912M | 3.292M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-09 | Truist Securities | Jailendra Singh | Maintains | HoldHold | Lowers | 12.00 | 10.00 |
2023-08-08 | Credit Suisse | Jonathan Yong | Reiterates | OutperformOutperform | Maintains | - | 14.00 |
2023-07-28 | TD Cowen | Jonna Kim | Initiates Coverage On | Outperform | Announces | - | 11.00 |
2023-06-15 | Tigress Financial | Ivan Feinseth | Reiterates | Buy | Raises | 12.00 | 14.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
HIMS | Hims & Hers Health | -1.1% | 1.3B |
CVS | CVS Health | -0.37% | 89.6B |
CHE | Chemed | -0.44% | 7.8B |
CCRN | Cross Country Healthcare | -2.13% | 887.5M |
PRVA | Privia Health Gr | 0% | 2.7B |
You can purchase shares of Hims & Hers Health (NYSE: HIMS) through any online brokerage.
Other companies in Hims & Hers Health’s space includes: CVS Health (NYSE:CVS), Chemed (NYSE:CHE), Cross Country Healthcare (NASDAQ:CCRN), Privia Health Gr (NASDAQ:PRVA) and Premier (NASDAQ:PINC).
The latest price target for Hims & Hers Health (NYSE: HIMS) was reported by Truist Securities on Wednesday, August 9, 2023. The analyst firm set a price target for 10.00 expecting HIMS to rise to within 12 months (a possible 58.98% upside). 21 analyst firms have reported ratings in the last year.
The stock price for Hims & Hers Health (NYSE: HIMS) is $6.29 last updated September 29, 2023 at 8:00 PM UTC.
There is no dividend information for Hims & Hers Health.
Hims & Hers Health’s Q3 earnings are confirmed for Monday, November 6, 2023.
There is no upcoming split for Hims & Hers Health.
Hims & Hers Health is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NYSE.
Hims & Hers Health Stock (NYSE: HIMS) stock price, news, charts, stock research, profile.
Open6.420 | Close6.290 |
Vol / Avg.2.028M / 2.833M | Mkt Cap1.327B |
Day Range6.240 - 6.540 | 52 Wk Range4.015 - 12.340 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.030 | (EXPECTED) 2023-11-06 | |||||
REV | 220.050M |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.060 | -0.030 | 0.0300 | ||||
REV | 204.620M | 207.912M | 3.292M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-09 | Truist Securities | Jailendra Singh | Maintains | HoldHold | Lowers | 12.00 | 10.00 |
2023-08-08 | Credit Suisse | Jonathan Yong | Reiterates | OutperformOutperform | Maintains | - | 14.00 |
2023-07-28 | TD Cowen | Jonna Kim | Initiates Coverage On | Outperform | Announces | - | 11.00 |
2023-06-15 | Tigress Financial | Ivan Feinseth | Reiterates | Buy | Raises | 12.00 | 14.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
HIMS | Hims & Hers Health | -1.1% | 1.3B |
CVS | CVS Health | -0.37% | 89.6B |
CHE | Chemed | -0.44% | 7.8B |
CCRN | Cross Country Healthcare | -2.13% | 887.5M |
PRVA | Privia Health Gr | 0% | 2.7B |
You can purchase shares of Hims & Hers Health (NYSE: HIMS) through any online brokerage.
Other companies in Hims & Hers Health’s space includes: CVS Health (NYSE:CVS), Chemed (NYSE:CHE), Cross Country Healthcare (NASDAQ:CCRN), Privia Health Gr (NASDAQ:PRVA) and Premier (NASDAQ:PINC).
The latest price target for Hims & Hers Health (NYSE: HIMS) was reported by Truist Securities on Wednesday, August 9, 2023. The analyst firm set a price target for 10.00 expecting HIMS to rise to within 12 months (a possible 58.98% upside). 21 analyst firms have reported ratings in the last year.
The stock price for Hims & Hers Health (NYSE: HIMS) is $6.29 last updated September 29, 2023 at 8:00 PM UTC.
There is no dividend information for Hims & Hers Health.
Hims & Hers Health’s Q3 earnings are confirmed for Monday, November 6, 2023.
There is no upcoming split for Hims & Hers Health.
Hims & Hers Health is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NYSE.
Hims & Hers Health Stock (NYSE: HIMS) stock price, news, charts, stock research, profile.
Open6.420 | Close6.290 |
Vol / Avg.2.028M / 2.833M | Mkt Cap1.327B |
Day Range6.240 - 6.540 | 52 Wk Range4.015 - 12.340 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.030 | (EXPECTED) 2023-11-06 | |||||
REV | 220.050M |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.060 | -0.030 | 0.0300 | ||||
REV | 204.620M | 207.912M | 3.292M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-09 | Truist Securities | Jailendra Singh | Maintains | HoldHold | Lowers | 12.00 | 10.00 |
2023-08-08 | Credit Suisse | Jonathan Yong | Reiterates | OutperformOutperform | Maintains | - | 14.00 |
2023-07-28 | TD Cowen | Jonna Kim | Initiates Coverage On | Outperform | Announces | - | 11.00 |
2023-06-15 | Tigress Financial | Ivan Feinseth | Reiterates | Buy | Raises | 12.00 | 14.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
HIMS | Hims & Hers Health | -1.1% | 1.3B |
CVS | CVS Health | -0.37% | 89.6B |
CHE | Chemed | -0.44% | 7.8B |
CCRN | Cross Country Healthcare | -2.13% | 887.5M |
PRVA | Privia Health Gr | 0% | 2.7B |
You can purchase shares of Hims & Hers Health (NYSE: HIMS) through any online brokerage.
Other companies in Hims & Hers Health’s space includes: CVS Health (NYSE:CVS), Chemed (NYSE:CHE), Cross Country Healthcare (NASDAQ:CCRN), Privia Health Gr (NASDAQ:PRVA) and Premier (NASDAQ:PINC).
The latest price target for Hims & Hers Health (NYSE: HIMS) was reported by Truist Securities on Wednesday, August 9, 2023. The analyst firm set a price target for 10.00 expecting HIMS to rise to within 12 months (a possible 58.98% upside). 21 analyst firms have reported ratings in the last year.
The stock price for Hims & Hers Health (NYSE: HIMS) is $6.29 last updated September 29, 2023 at 8:00 PM UTC.
There is no dividend information for Hims & Hers Health.
Hims & Hers Health’s Q3 earnings are confirmed for Monday, November 6, 2023.
There is no upcoming split for Hims & Hers Health.
Hims & Hers Health is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NYSE.
Hims & Hers Health Stock (NYSE: HIMS) stock price, news, charts, stock research, profile.
Open6.420 | Close6.290 |
Vol / Avg.2.028M / 2.833M | Mkt Cap1.327B |
Day Range6.240 - 6.540 | 52 Wk Range4.015 - 12.340 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.030 | (EXPECTED) 2023-11-06 | |||||
REV | 220.050M |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.060 | -0.030 | 0.0300 | ||||
REV | 204.620M | 207.912M | 3.292M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-09 | Truist Securities | Jailendra Singh | Maintains | HoldHold | Lowers | 12.00 | 10.00 |
2023-08-08 | Credit Suisse | Jonathan Yong | Reiterates | OutperformOutperform | Maintains | - | 14.00 |
2023-07-28 | TD Cowen | Jonna Kim | Initiates Coverage On | Outperform | Announces | - | 11.00 |
2023-06-15 | Tigress Financial | Ivan Feinseth | Reiterates | Buy | Raises | 12.00 | 14.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
HIMS | Hims & Hers Health | -1.1% | 1.3B |
CVS | CVS Health | -0.37% | 89.6B |
CHE | Chemed | -0.44% | 7.8B |
CCRN | Cross Country Healthcare | -2.13% | 887.5M |
PRVA | Privia Health Gr | 0% | 2.7B |
You can purchase shares of Hims & Hers Health (NYSE: HIMS) through any online brokerage.
Other companies in Hims & Hers Health’s space includes: CVS Health (NYSE:CVS), Chemed (NYSE:CHE), Cross Country Healthcare (NASDAQ:CCRN), Privia Health Gr (NASDAQ:PRVA) and Premier (NASDAQ:PINC).
The latest price target for Hims & Hers Health (NYSE: HIMS) was reported by Truist Securities on Wednesday, August 9, 2023. The analyst firm set a price target for 10.00 expecting HIMS to rise to within 12 months (a possible 58.98% upside). 21 analyst firms have reported ratings in the last year.
The stock price for Hims & Hers Health (NYSE: HIMS) is $6.29 last updated September 29, 2023 at 8:00 PM UTC.
There is no dividend information for Hims & Hers Health.
Hims & Hers Health’s Q3 earnings are confirmed for Monday, November 6, 2023.
There is no upcoming split for Hims & Hers Health.
Hims & Hers Health is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NYSE.
Hims & Hers Health Stock (NYSE: HIMS) stock price, news, charts, stock research, profile.
Open6.420 | Close6.290 |
Vol / Avg.2.028M / 2.833M | Mkt Cap1.327B |
Day Range6.240 - 6.540 | 52 Wk Range4.015 - 12.340 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.030 | (EXPECTED) 2023-11-06 | |||||
REV | 220.050M |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.060 | -0.030 | 0.0300 | ||||
REV | 204.620M | 207.912M | 3.292M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-09 | Truist Securities | Jailendra Singh | Maintains | HoldHold | Lowers | 12.00 | 10.00 |
2023-08-08 | Credit Suisse | Jonathan Yong | Reiterates | OutperformOutperform | Maintains | - | 14.00 |
2023-07-28 | TD Cowen | Jonna Kim | Initiates Coverage On | Outperform | Announces | - | 11.00 |
2023-06-15 | Tigress Financial | Ivan Feinseth | Reiterates | Buy | Raises | 12.00 | 14.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
HIMS | Hims & Hers Health | -1.1% | 1.3B |
CVS | CVS Health | -0.37% | 89.6B |
CHE | Chemed | -0.44% | 7.8B |
CCRN | Cross Country Healthcare | -2.13% | 887.5M |
PRVA | Privia Health Gr | 0% | 2.7B |
You can purchase shares of Hims & Hers Health (NYSE: HIMS) through any online brokerage.
Other companies in Hims & Hers Health’s space includes: CVS Health (NYSE:CVS), Chemed (NYSE:CHE), Cross Country Healthcare (NASDAQ:CCRN), Privia Health Gr (NASDAQ:PRVA) and Premier (NASDAQ:PINC).
The latest price target for Hims & Hers Health (NYSE: HIMS) was reported by Truist Securities on Wednesday, August 9, 2023. The analyst firm set a price target for 10.00 expecting HIMS to rise to within 12 months (a possible 58.98% upside). 21 analyst firms have reported ratings in the last year.
The stock price for Hims & Hers Health (NYSE: HIMS) is $6.29 last updated September 29, 2023 at 8:00 PM UTC.
There is no dividend information for Hims & Hers Health.
Hims & Hers Health’s Q3 earnings are confirmed for Monday, November 6, 2023.
There is no upcoming split for Hims & Hers Health.
Hims & Hers Health is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NYSE.
Hims & Hers Health Stock (NYSE: HIMS) stock price, news, charts, stock research, profile.
Open6.420 | Close6.290 |
Vol / Avg.2.028M / 2.833M | Mkt Cap1.327B |
Day Range6.240 - 6.540 | 52 Wk Range4.015 - 12.340 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.030 | (EXPECTED) 2023-11-06 | |||||
REV | 220.050M |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.060 | -0.030 | 0.0300 | ||||
REV | 204.620M | 207.912M | 3.292M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-09 | Truist Securities | Jailendra Singh | Maintains | HoldHold | Lowers | 12.00 | 10.00 |
2023-08-08 | Credit Suisse | Jonathan Yong | Reiterates | OutperformOutperform | Maintains | - | 14.00 |
2023-07-28 | TD Cowen | Jonna Kim | Initiates Coverage On | Outperform | Announces | - | 11.00 |
2023-06-15 | Tigress Financial | Ivan Feinseth | Reiterates | Buy | Raises | 12.00 | 14.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
HIMS | Hims & Hers Health | -1.1% | 1.3B |
CVS | CVS Health | -0.37% | 89.6B |
CHE | Chemed | -0.44% | 7.8B |
CCRN | Cross Country Healthcare | -2.13% | 887.5M |
PRVA | Privia Health Gr | 0% | 2.7B |
You can purchase shares of Hims & Hers Health (NYSE: HIMS) through any online brokerage.
Other companies in Hims & Hers Health’s space includes: CVS Health (NYSE:CVS), Chemed (NYSE:CHE), Cross Country Healthcare (NASDAQ:CCRN), Privia Health Gr (NASDAQ:PRVA) and Premier (NASDAQ:PINC).
The latest price target for Hims & Hers Health (NYSE: HIMS) was reported by Truist Securities on Wednesday, August 9, 2023. The analyst firm set a price target for 10.00 expecting HIMS to rise to within 12 months (a possible 58.98% upside). 21 analyst firms have reported ratings in the last year.
The stock price for Hims & Hers Health (NYSE: HIMS) is $6.29 last updated September 29, 2023 at 8:00 PM UTC.
There is no dividend information for Hims & Hers Health.
Hims & Hers Health’s Q3 earnings are confirmed for Monday, November 6, 2023.
There is no upcoming split for Hims & Hers Health.
Hims & Hers Health is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NYSE.
Hims & Hers Health Stock (NYSE: HIMS) stock price, news, charts, stock research, profile.
Open6.420 | Close6.290 |
Vol / Avg.2.028M / 2.833M | Mkt Cap1.327B |
Day Range6.240 - 6.540 | 52 Wk Range4.015 - 12.340 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.030 | (EXPECTED) 2023-11-06 | |||||
REV | 220.050M |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.060 | -0.030 | 0.0300 | ||||
REV | 204.620M | 207.912M | 3.292M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-09 | Truist Securities | Jailendra Singh | Maintains | HoldHold | Lowers | 12.00 | 10.00 |
2023-08-08 | Credit Suisse | Jonathan Yong | Reiterates | OutperformOutperform | Maintains | - | 14.00 |
2023-07-28 | TD Cowen | Jonna Kim | Initiates Coverage On | Outperform | Announces | - | 11.00 |
2023-06-15 | Tigress Financial | Ivan Feinseth | Reiterates | Buy | Raises | 12.00 | 14.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
HIMS | Hims & Hers Health | -1.1% | 1.3B |
CVS | CVS Health | -0.37% | 89.6B |
CHE | Chemed | -0.44% | 7.8B |
CCRN | Cross Country Healthcare | -2.13% | 887.5M |
PRVA | Privia Health Gr | 0% | 2.7B |
You can purchase shares of Hims & Hers Health (NYSE: HIMS) through any online brokerage.
Other companies in Hims & Hers Health’s space includes: CVS Health (NYSE:CVS), Chemed (NYSE:CHE), Cross Country Healthcare (NASDAQ:CCRN), Privia Health Gr (NASDAQ:PRVA) and Premier (NASDAQ:PINC).
The latest price target for Hims & Hers Health (NYSE: HIMS) was reported by Truist Securities on Wednesday, August 9, 2023. The analyst firm set a price target for 10.00 expecting HIMS to rise to within 12 months (a possible 58.98% upside). 21 analyst firms have reported ratings in the last year.
The stock price for Hims & Hers Health (NYSE: HIMS) is $6.29 last updated September 29, 2023 at 8:00 PM UTC.
There is no dividend information for Hims & Hers Health.
Hims & Hers Health’s Q3 earnings are confirmed for Monday, November 6, 2023.
There is no upcoming split for Hims & Hers Health.
Hims & Hers Health is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NYSE.
Hims & Hers Health Stock (NYSE: HIMS) stock price, news, charts, stock research, profile.
Open6.420 | Close6.290 |
Vol / Avg.2.028M / 2.833M | Mkt Cap1.327B |
Day Range6.240 - 6.540 | 52 Wk Range4.015 - 12.340 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.030 | (EXPECTED) 2023-11-06 | |||||
REV | 220.050M |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.060 | -0.030 | 0.0300 | ||||
REV | 204.620M | 207.912M | 3.292M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-09 | Truist Securities | Jailendra Singh | Maintains | HoldHold | Lowers | 12.00 | 10.00 |
2023-08-08 | Credit Suisse | Jonathan Yong | Reiterates | OutperformOutperform | Maintains | - | 14.00 |
2023-07-28 | TD Cowen | Jonna Kim | Initiates Coverage On | Outperform | Announces | - | 11.00 |
2023-06-15 | Tigress Financial | Ivan Feinseth | Reiterates | Buy | Raises | 12.00 | 14.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
HIMS | Hims & Hers Health | -1.1% | 1.3B |
CVS | CVS Health | -0.37% | 89.6B |
CHE | Chemed | -0.44% | 7.8B |
CCRN | Cross Country Healthcare | -2.13% | 887.5M |
PRVA | Privia Health Gr | 0% | 2.7B |
You can purchase shares of Hims & Hers Health (NYSE: HIMS) through any online brokerage.
Other companies in Hims & Hers Health’s space includes: CVS Health (NYSE:CVS), Chemed (NYSE:CHE), Cross Country Healthcare (NASDAQ:CCRN), Privia Health Gr (NASDAQ:PRVA) and Premier (NASDAQ:PINC).
The latest price target for Hims & Hers Health (NYSE: HIMS) was reported by Truist Securities on Wednesday, August 9, 2023. The analyst firm set a price target for 10.00 expecting HIMS to rise to within 12 months (a possible 58.98% upside). 21 analyst firms have reported ratings in the last year.
The stock price for Hims & Hers Health (NYSE: HIMS) is $6.29 last updated September 29, 2023 at 8:00 PM UTC.
There is no dividend information for Hims & Hers Health.
Hims & Hers Health’s Q3 earnings are confirmed for Monday, November 6, 2023.
There is no upcoming split for Hims & Hers Health.
Hims & Hers Health is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NYSE.
Hims & Hers Health Stock (NYSE: HIMS) stock price, news, charts, stock research, profile.
Open6.420 | Close6.290 |
Vol / Avg.2.028M / 2.833M | Mkt Cap1.327B |
Day Range6.240 - 6.540 | 52 Wk Range4.015 - 12.340 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.030 | (EXPECTED) 2023-11-06 | |||||
REV | 220.050M |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.060 | -0.030 | 0.0300 | ||||
REV | 204.620M | 207.912M | 3.292M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-09 | Truist Securities | Jailendra Singh | Maintains | HoldHold | Lowers | 12.00 | 10.00 |
2023-08-08 | Credit Suisse | Jonathan Yong | Reiterates | OutperformOutperform | Maintains | - | 14.00 |
2023-07-28 | TD Cowen | Jonna Kim | Initiates Coverage On | Outperform | Announces | - | 11.00 |
2023-06-15 | Tigress Financial | Ivan Feinseth | Reiterates | Buy | Raises | 12.00 | 14.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
HIMS | Hims & Hers Health | -1.1% | 1.3B |
CVS | CVS Health | -0.37% | 89.6B |
CHE | Chemed | -0.44% | 7.8B |
CCRN | Cross Country Healthcare | -2.13% | 887.5M |
PRVA | Privia Health Gr | 0% | 2.7B |
You can purchase shares of Hims & Hers Health (NYSE: HIMS) through any online brokerage.
Other companies in Hims & Hers Health’s space includes: CVS Health (NYSE:CVS), Chemed (NYSE:CHE), Cross Country Healthcare (NASDAQ:CCRN), Privia Health Gr (NASDAQ:PRVA) and Premier (NASDAQ:PINC).
The latest price target for Hims & Hers Health (NYSE: HIMS) was reported by Truist Securities on Wednesday, August 9, 2023. The analyst firm set a price target for 10.00 expecting HIMS to rise to within 12 months (a possible 58.98% upside). 21 analyst firms have reported ratings in the last year.
The stock price for Hims & Hers Health (NYSE: HIMS) is $6.29 last updated September 29, 2023 at 8:00 PM UTC.
There is no dividend information for Hims & Hers Health.
Hims & Hers Health’s Q3 earnings are confirmed for Monday, November 6, 2023.
There is no upcoming split for Hims & Hers Health.
Hims & Hers Health is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NYSE.